Skip to main content

Advertisement

Log in

A case of neurodegenerative Langerhans cell histiocytosis exhibiting high osteopontin in cerebrospinal fluid without specific radiological abnormalities

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Neurodegenerative Langerhans cell histiocytosis (ND-LCH) manifests several years after onset of LCH, with progressive neurological symptoms and characteristic brain imaging features. Although ND-LCH has a dismal neurological prognosis, distinct treatment strategies are not available owing to the unknown pathophysiology. We describe the case of a 6-year-old boy who developed left convergent strabismus four years after onset of multisystem LCH (MS-LCH). Although radiological imaging showed no abnormalities, the osteopontin level in the cerebrospinal fluid (CSF-OPN) was highly elevated without other abnormal CSF findings, leading to a diagnosis of ND-LCH. The patient received monthly intravenous immunoglobulin therapy for four years, without symptoms worsening. To investigate the relevance of OPN levels in LCH, we retrospectively analyzed serum and CSF OPN levels in eight LCH patients. Serum OPN levels were markedly elevated in the two MS-LCH patients with macrophage activation (400 and 445 ng/mL) compared to the other six patients (mean: 59 ng/mL). CSF-OPN levels were elevated in the ND-LCH patient (620 ng/mL) compared to the two patients with pituitary involvement (160 and 182 ng/mL), suggesting that the pathophysiology of ND-LCH reflects its inflammatory status. Analysis of CSF-OPN levels would be a useful tool to detect and treat ND-LCH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

All data generated in this study are included in this manuscript. Further inquiries can be directed to the corresponding author.

References

  1. Morimoto A, Oh Y, Shioda Y, Kudo K, Imamura T. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451–61.

    Article  CAS  PubMed  Google Scholar 

  2. Ikawa Y, Nishimura R, Araki R, Noguchi K, Muraoka M, Fukuda M, et al. Pathognomonic serum cytokine profiles identify life-threatening Langerhans cell histiocytosis. Br J Haematol. 2017;176:495–7.

    Article  PubMed  Google Scholar 

  3. Martin-Duverneuil N, Idbaih A, Hoang-Xuan K, Donadieu J, Genereau T, Guillevin R, et al. MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol. 2006;16:2074–82.

    Article  CAS  PubMed  Google Scholar 

  4. Héritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, et al. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study. Br J Haematol. 2018;183:608–17.

    Article  PubMed  Google Scholar 

  5. Sakamoto K, Morimoto A, Shioda Y, Imamura T, Imashuku S, Japan LCH Study Group. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: results from the JLSG-96/02 studies. Pediatr Blood Cancer. 2019;66:e27454.

    Article  PubMed  Google Scholar 

  6. Imashuku S, Fujita N, Shioda Y, Noma H, Seto S, Minato T, et al. Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease. Int J Hematol. 2015;101:191–7.

    Article  PubMed  Google Scholar 

  7. Eskstein O, McAtee CL, Greenberg J, Kumar A, Fein-Levy C, Smith T, et al. Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction. Pediatr Hematol Oncol. 2018;35:427–33.

    Article  Google Scholar 

  8. Chohan G, Barnett Y, Gibson J, Reddel SWR, Barnett MH. Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. J Neurol Neurosurg Psychiatry. 2012;83(5):573–5.

    Article  PubMed  Google Scholar 

  9. Allen CE, Flores R, Rauch R, Dauser R, Murray JM, Puccetti D, et al. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatr Blood Cancer. 2010;54:416–23.

    Article  PubMed Central  PubMed  Google Scholar 

  10. McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, et al. CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions. Cancer. 2018;124:2607–20.

    Article  CAS  PubMed  Google Scholar 

  11. Guennec LL, Decaix C, Donadieu J, Santiago-Ribeiro M, Martin-Duverneuil N, Levy R, et al. The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis. J Neurol. 2014;261:1537–43.

    Article  PubMed  Google Scholar 

  12. Lamort AS, Giopanou I, Psallidas I, Stathopoulos GT. Osteopontin as a link between inflammation and cancer: the thorax in the spotlight. Cells. 2019;8:815.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Allen CE, Li L, Peters TL, Leung HE, Yu A, Man TK, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184:4557–67.

    Article  CAS  PubMed  Google Scholar 

  14. Idbaih A, Donadieu J, Barthez MA, Geissmann F, Bertrnd Y, Hermine O, et al. Retinoic acid therapy in “degenerative-like” neuro-langerhans cell histiocytosis: a prospective pilot study. Pediatr Blood Cancer. 2004;43:55–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuhiro Ikawa.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakai, Y., Ikawa, Y., Takenaka, M. et al. A case of neurodegenerative Langerhans cell histiocytosis exhibiting high osteopontin in cerebrospinal fluid without specific radiological abnormalities. Int J Hematol 118, 661–665 (2023). https://doi.org/10.1007/s12185-023-03639-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-023-03639-2

Keywords

Navigation